- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01551485
Postoperative Sleep Disturbances After Zolpidem Treatment in Fast-track Hip and Knee Replacement
August 7, 2012 updated by: Lene Krenk, Rigshospitalet, Denmark
Sleep after surgery has been found to be very distrubed immediately after major surgery.
This is also seen after fast-track hip and knee replacement with length of stay of less than 3 days.
Disturbed sleep has many adverse effects i.e. fatigue, possible hyperalgesia and decline in cognitive abilities.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Gentofte, Denmark
- Gentofte Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Total hip or knee replacement in fast-track setup
- Age 60 years or above
- ASA class 1-3
Exclusion Criteria:
- Anesthesia within the pas 30 days
- Daily use of alcohol > 21 units / week
- Use of anxiolytics or hypnotics within the past 30 days
- Inability to read and understand Danish
- Marked reduction of sight or hearing
- Parkinson's disease or other neurological disaese causing function deficits
- Inability to cooperate to sleep monitoring
- allergy to the drug tested
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Placebo
|
Pacebo tablet, blinded given on the first night after surgery
|
|
EXPERIMENTAL: Zolpidem
|
The effect of Zolpidem 10 mg for the first night after surgery is asssessed using PSG
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sleep time on the first postoperative night compared to preoperatively.
Time Frame: first night postoperatively - 24 hours
|
The primary endpoint is an evaluation of sleep stages on the first night postoperatively compared to preoperative measures for the same individual
|
first night postoperatively - 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (ANTICIPATED)
August 1, 2012
Study Completion (ANTICIPATED)
October 1, 2012
Study Registration Dates
First Submitted
February 6, 2012
First Submitted That Met QC Criteria
March 7, 2012
First Posted (ESTIMATE)
March 12, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
August 8, 2012
Last Update Submitted That Met QC Criteria
August 7, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Sleep Wake Disorders
- Dyssomnias
- Parasomnias
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Hypnotics and Sedatives
- GABA Agents
- Sleep Aids, Pharmaceutical
- GABA-A Receptor Agonists
- GABA Agonists
- Zolpidem
Other Study ID Numbers
- H-3-2011-022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Duration on the First Night After Surgery
-
Showa UniversityCompletedto Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract SurgeryJapan
Clinical Trials on Zolpidem
-
EMSAssociação Fundo de Incentivo à PesquisaCompleted
-
Henry Ford Health SystemCompleted
-
University of PennsylvaniaNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedInsomnia | Insomnia ChronicUnited States
-
University of Southern CaliforniaRecruitingPain, Postoperative | Spine Fusion | Lumbar Spine Degeneration | Lumbar Spine SpondylosisUnited States
-
Biolab Sanus FarmaceuticaCompleted
-
Biolab Sanus FarmaceuticaCompleted
-
TakedaCompletedChronic InsomniaUnited States
-
Eisai Inc.Purdue Pharma LPCompleted
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedSleep Initiation and Maintenance Disorders | Primary InsomniaTaiwan
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, Canada, Australia